| 4.83 -0.07 (-1.43%) | 05-29 15:59 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 6.56 | 1-year : | 7.94 |
| Resists | First : | 5.61 | Second : | 6.8 |
| Pivot price | 5.07 |
|||
| Supports | First : | 3.71 | Second : | 3.08 |
| MAs | MA(5) : | 4.88  |
MA(20) : | 4.99 |
| MA(100) : | 4.14 |
MA(250) : | 4.85 |
|
| MACD | MACD : | 0.1 |
Signal : | 0.2 |
| %K %D | K(14,3) : | 19.9 |
D(3) : | 22.3 |
| RSI | RSI(14): 53.1 |
|||
| 52-week | High : | 10.77 | Low : | 3.18 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ CCM ] has closed above bottom band by 28.8%. Bollinger Bands are 12.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 5.53 - 5.55 | 5.55 - 5.58 |
| Low: | 4.76 - 4.79 | 4.79 - 4.82 |
| Close: | 4.77 - 4.82 | 4.82 - 4.87 |
Concord Medical Services Holdings Limited, together its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. The company operates in two segments, Network and Hospital. Its services include linear accelerators external beam radiotherapy, gamma knife radiosurgery, head gamma knife systems, body gamma knife systems, and diagnostic imaging services. The company's other treatments and diagnostic services comprise computed tomography scanners. In addition, it provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, the company offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, it operates specialty cancer hospitals, which offer radiotherapy services, diagnostic imaging services, chemotherapy, and surgery. As of December 31, 2021, it operated a network of 16 cooperative centers based in 13 hospitals. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, the People's Republic of China.
Mon, 18 May 2026
Concord Medical announces board changes at Concord Healthcare subsidiary - Investing.com
Wed, 13 May 2026
Concord Medical’s Hong Kong Subsidiary Reshapes Board Leadership After AGM - TipRanks
Wed, 13 May 2026
Concord Healthcare issues HK$68 million in 2% convertible bonds due 2027 - Investing.com
Wed, 29 Apr 2026
Concord Medical Files Annual Report on Form 20-F for the Fiscal Year 2025 - Barchart.com
Tue, 28 Apr 2026
Concord Medical Services Holdings Limited Auditor Raises 'Going Concern' Doubt - marketscreener.com
Tue, 03 Jun 2025
Concord Healthcare Unveils China’s First Proton Therapy-Focused Large Language Model - BioPharma APAC
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Care Facilities
|
|
| Shares Out | 3 (M) |
| Shares Float | 42 (M) |
| Held by Insiders | 18 (%) |
| Held by Institutions | 0.4 (%) |
| Shares Short | 3 (K) |
| Shares Short P.Month | 3 (K) |
| EPS | -3.15 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -71.39 |
| Profit Margin | -20.2 % |
| Operating Margin | -36.5 % |
| Return on Assets (ttm) | -2.3 % |
| Return on Equity (ttm) | -21.9 % |
| Qtrly Rev. Growth | 57.4 % |
| Gross Profit (p.s.) | 9.15 |
| Sales Per Share | 163.3 |
| EBITDA (p.s.) | -35.36 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -202 (M) |
| Levered Free Cash Flow | -314 (M) |
| PE Ratio | -1.54 |
| PEG Ratio | 0.5 |
| Price to Book value | -0.07 |
| Price to Sales | 0.02 |
| Price to Cash Flow | -0.07 |
| Dividend | 9.89 |
| Forward Dividend | 0 |
| Dividend Yield | 204.9% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|